# USF 4.0: Example Adaptations

> **Version**: 4.0.0
> **Component**: Integration / Example Adaptations
> **Status**: Specification
> **Dependencies**: All core and integration specifications

---

## 1. Overview

This document provides concrete examples of USF 4.0 adapting to different domains and task types, demonstrating the framework's universal adaptability.

---

## 2. Security Domain Example

### 2.1 Task: Cryptographic Protocol Analysis

```yaml
task:
  input: |
    Analyze the security of the VEIL V17 anonymous communication protocol.
    Focus on sender anonymity guarantees against a global passive adversary.
    The protocol uses X25519 for key exchange and ChaCha20-Poly1305 for
    symmetric encryption with a custom routing mechanism.

  domain_detection:
    lexical_signals:
      matches: ["X25519", "ChaCha20-Poly1305", "anonymity", "adversary", "protocol"]
      domain_hints: ["T.SEC.CRY", "T.SEC.PRO"]

    semantic_signals:
      embedding_similarity:
        T.SEC.CRY: 0.89
        T.SEC.PRO: 0.87
        T.SEC.PRV: 0.75

    result:
      primary: "T.SEC.PRO.ANO"
      secondary: ["T.SEC.CRY.ASY", "T.NET.PRO"]
      confidence: 0.91

  precision_calibration:
    factors:
      CS: 5  # Anonymity failure is catastrophic
      DC: 4  # Complex protocol analysis
      AE: 5  # Global passive adversary (nation-state)
      VA: 4  # Formal methods applicable
      TC: 2  # No rush

    calculation:
      raw: "5+4+5+4-2 = 16"
      normalized: "17/5 = 3.4"
      base_level: "PL4"

    overrides:
      - "Nation-state adversary → PL4 minimum (already met)"
      - "Cryptographic protocol → PL3 minimum (already exceeded)"

    result: "PL4 (Verified)"

  expert_panel:
    size: 15
    composition:
      ARC-TH: 4  # Heavy theoretical for proofs
        - "Dr. Sarah Chen - Provable security specialist"
        - "Prof. Michael Wang - Information theory"
        - "Dr. Elena Kowalski - Protocol verification"
        - "Prof. James Morrison - Cryptographic foundations"

      ARC-AD: 5  # Strong adversarial for attacks
        - "Marcus Black - NSA TAO veteran, cryptanalyst"
        - "Dr. Yuki Tanaka - Traffic analysis specialist"
        - "Alex Rivera - Protocol exploitation expert"
        - "Dr. Fatima Al-Hassan - Side-channel attacks"
        - "Chris O'Brien - APT threat modeling"

      ARC-IM: 3  # Implementation review
        - "Dr. David Kim - Secure implementation"
        - "Anna Petrov - Cryptographic engineering"
        - "Robert Chen - Systems security"

      ARC-ST: 2  # Strategic oversight
        - "Dr. Jennifer Park - Security architecture"
        - "Thomas Anderson - Threat intelligence"

      ARC-QA: 1  # Verification
        - "Dr. Lisa Martinez - Formal verification"

    roles:
      LEAD: "Dr. Jennifer Park"
      SYNTHESIZER: "Prof. Michael Wang"

  template_selection:
    primary: "TMPL-SEC"
    adapted_phases:
      - "Phase 1: Threat Model & Attack Surface"
      - "Phase 2: Protocol Formal Specification"
      - "Phase 3: Cryptographic Primitive Analysis"
      - "Phase 4: Protocol-Level Attack Analysis"
      - "Phase 5: Implementation Considerations"
      - "Phase 6: Countermeasure Verification"
      - "Phase 7: Synthesis & Proof Construction"

  execution_highlights:
    phase_2_formal_spec:
      output: |
        Formal specification in applied pi-calculus:
        - Defined sender, receiver, router processes
        - Specified adversary capabilities (global passive)
        - Formalized anonymity as observational equivalence

    phase_4_attack_analysis:
      attacks_considered:
        - "Timing correlation attacks"
        - "Traffic analysis (volume, timing, size)"
        - "Intersection attacks"
        - "Long-term statistical attacks"
        - "Cryptographic attacks on primitives"

      findings:
        - "CRITICAL: Timing correlation possible if latency not padded"
        - "HIGH: Volume analysis reveals activity patterns"
        - "MEDIUM: Long-term intersection reduces anonymity set"

    phase_6_verification:
      methods:
        - "ProVerif model checking for anonymity properties"
        - "Tamarin prover for authentication"
        - "Manual proof sketches for information-theoretic claims"

      results:
        - "Anonymity: Verified under stated adversary model"
        - "Unlinkability: Verified with caveats on timing"
        - "Undetectability: NOT verified - requires additional measures"

  verification_chains:
    CHAIN-A: "Static protocol analysis - VERIFIED with caveats"
    CHAIN-B: "Dynamic simulation testing - VERIFIED"
    CHAIN-C: "Formal verification (ProVerif) - VERIFIED"
    CHAIN-D: "Reference implementation testing - VERIFIED"
    CHAIN-E: "Expert panel consensus - VERIFIED with conditions"

    agreement: "5/5 (unanimous with documented caveats)"

  output:
    confidence: 0.94
    verdict: |
      VEIL V17 provides provable sender anonymity against global passive
      adversaries UNDER the following conditions:
      1. Timing must be uniformly padded to constant intervals
      2. Message sizes must be padded to uniform length
      3. Volume must be managed with cover traffic

      WITHOUT these mitigations:
      - Timing correlation attacks are feasible
      - Volume analysis reveals activity patterns

    recommendations:
      - "CRITICAL: Implement constant-time message processing"
      - "HIGH: Add cover traffic generation"
      - "MEDIUM: Implement uniform message sizing"
```

---

## 3. Business Domain Example

### 3.1 Task: Market Entry Strategy

```yaml
task:
  input: |
    Evaluate market entry strategy for a B2B SaaS security monitoring
    platform targeting the European healthcare sector. Consider regulatory
    requirements (GDPR, medical device regulations), competitive landscape,
    and go-to-market approach.

  domain_detection:
    result:
      primary: "B.STR.CPT"
      secondary: ["L.REG.PRI", "L.REG.HEA", "T.SEC"]
      confidence: 0.88

  precision_calibration:
    factors:
      CS: 3  # Significant business decision
      DC: 4  # Complex multi-domain analysis
      AE: 2  # Competitive, not adversarial
      VA: 3  # Market research available
      TC: 3  # Normal timeline

    result: "PL2 (Detailed)"

  expert_panel:
    size: 9
    composition:
      ARC-ST: 3
        - "Jennifer Park - Strategy consulting partner"
        - "Marcus Chen - Healthcare market strategist"
        - "Dr. Anna Müller - European market specialist"

      ARC-TH: 2
        - "Prof. David Morrison - Market dynamics theory"
        - "Dr. Lisa Wang - Regulatory analysis"

      ARC-AD: 2
        - "Thomas Black - Competitive intelligence"
        - "Sarah O'Connor - Risk assessment"

      ARC-IM: 1
        - "Robert Chen - Go-to-market execution"

      ARC-QA: 1
        - "Dr. Elena Kowalski - Market validation"

  template_selection:
    primary: "TMPL-BUS"
    secondary_fusion: "TMPL-LEG (for regulatory analysis)"

  execution_highlights:
    situational_analysis:
      market_size: "€2.3B addressable in EU healthcare security"
      growth_rate: "18% CAGR"
      competitive_landscape:
        leaders: ["Company A", "Company B"]
        differentiators: "Limited healthcare-specific solutions"
        gaps: "GDPR + MDR combined compliance tools"

    regulatory_analysis:
      gdpr_requirements:
        - "Data processing agreements required"
        - "DPO appointment for healthcare data"
        - "Cross-border transfer mechanisms"
      mdr_requirements:
        - "If monitoring medical devices: MDR classification"
        - "Potential notified body involvement"
        - "QMS requirements"

    strategy_options:
      option_1: "Direct entry via Germany (largest market)"
      option_2: "Partnership with established healthcare IT vendor"
      option_3: "Regulatory sandbox entry via UK/Netherlands"

    stress_testing:
      downside_scenarios:
        - "Regulatory delays (18 months): Adjust timeline, not viability"
        - "Strong competitive response: Differentiate on compliance depth"
        - "Brexit impact: Separate UK strategy"

  output:
    confidence: 0.87
    recommendation: |
      RECOMMENDED: Option 2 (Partnership strategy)

      Rationale:
      - Faster regulatory navigation with established partner
      - Immediate market access and credibility
      - Lower initial capital requirement
      - Risk sharing on regulatory compliance

    implementation_roadmap:
      - "Q1: Partner identification and outreach"
      - "Q2: Partnership negotiation and structuring"
      - "Q3: Joint product adaptation for healthcare"
      - "Q4: Pilot with 2-3 hospital systems"
      - "Year 2: Expand to 3 additional EU markets"

    key_risks:
      - "Partner dependency: Mitigate with multiple partners"
      - "Regulatory changes: Monitor actively, build flexibility"
      - "Competitive response: Move quickly, establish position"
```

---

## 4. Scientific Domain Example

### 4.1 Task: Research Methodology Review

```yaml
task:
  input: |
    Review the methodology of a proposed clinical trial studying a novel
    AI-based diagnostic system for early cancer detection. The trial
    proposes using retrospective data from 5 hospital systems with
    prospective validation at 2 sites.

  domain_detection:
    result:
      primary: "S.MED.DIA"
      secondary: ["T.DAT.ML", "S.STA.EXP"]
      confidence: 0.93

  precision_calibration:
    factors:
      CS: 5  # Medical diagnostic - life/death implications
      DC: 4  # Complex methodology
      AE: 1  # No adversary
      VA: 4  # Standard validation methods
      TC: 2  # Thorough review needed

    result: "PL3 (Formal)"
    override: "Medical safety → PL3 minimum (met)"

  expert_panel:
    size: 11
    composition:
      ARC-TH: 4
        - "Prof. Elizabeth Chen - Biostatistics"
        - "Dr. Michael Park - Clinical trial design"
        - "Dr. Anna Morrison - Epidemiology"
        - "Prof. James Wang - ML validation methodology"

      ARC-AD: 2
        - "Dr. Sarah Black - Clinical trial critique"
        - "Dr. David Kim - Bias detection specialist"

      ARC-IM: 2
        - "Dr. Lisa Chen - Clinical implementation"
        - "Dr. Robert Miller - ML systems validation"

      ARC-QA: 2
        - "Dr. Jennifer O'Brien - Regulatory compliance (FDA)"
        - "Dr. Thomas Anderson - Trial protocol validation"

      ARC-ST: 1
        - "Dr. Marcus White - Clinical research strategy"

  template_selection:
    primary: "TMPL-SCI"
    adapted_for: "Clinical trial methodology review"

  execution_highlights:
    methodology_analysis:
      strengths:
        - "Multi-center design improves generalizability"
        - "Prospective validation addresses temporal bias"
        - "Large retrospective dataset for training"

      weaknesses_identified:
        - "CRITICAL: Selection bias in retrospective data"
        - "HIGH: Potential label noise from varied annotation"
        - "HIGH: Distribution shift between sites"
        - "MEDIUM: Demographic representation unclear"

    formal_assessment:
      statistical_power:
        calculation: "For sensitivity 0.90 vs 0.85, n=2000 needed"
        proposed: "n=5000 retrospective, n=500 prospective"
        assessment: "Adequate for primary endpoint"

      bias_analysis:
        spectrum_bias: "Risk: HIGH - single-center predominance"
        verification_bias: "Risk: MEDIUM - not all patients biopsied"
        incorporation_bias: "Risk: LOW - independent gold standard"

    recommendations:
      critical:
        - "Implement stratified sampling by site and demographics"
        - "Add external validation site not in training data"
        - "Document and address annotation protocol differences"

      important:
        - "Pre-register analysis protocol"
        - "Define subgroup analyses a priori"
        - "Plan for device-specific degradation analysis"

  output:
    confidence: 0.91
    verdict: |
      The proposed methodology is CONDITIONALLY ADEQUATE pending:
      1. Addition of external validation site
      2. Stratified sampling implementation
      3. Pre-registration of statistical analysis plan

    uncertainty:
      epistemic:
        - "Actual site-to-site variability unknown until data collected"
        - "Annotation quality cannot be fully assessed a priori"
      aleatory:
        - "Patient population will vary from training"
        - "Device performance may degrade over time"
```

---

## 5. Legal Domain Example

### 5.1 Task: Privacy Regulation Compliance

```yaml
task:
  input: |
    Assess whether our data analytics platform's use of behavioral
    tracking and profiling for personalized advertising complies with
    GDPR requirements, particularly Article 22 (automated decision-making)
    and legitimate interest basis.

  domain_detection:
    result:
      primary: "L.REG.PRI"
      secondary: ["T.DAT.ANL", "B.MKT.DIG"]
      confidence: 0.94

  precision_calibration:
    result: "PL3"
    rationale: "Regulatory compliance requires formal rigor"

  expert_panel:
    size: 9
    composition:
      ARC-TH: 3
        - "Prof. Elena Schmidt - EU Data Protection Law"
        - "Dr. James Morrison - Privacy regulation expert"
        - "Dr. Anna Chen - Constitutional law (privacy)"

      ARC-AD: 2
        - "Dr. Marcus Black - DPA enforcement specialist"
        - "Sarah O'Connor - Privacy advocacy perspective"

      ARC-IM: 2
        - "Dr. Lisa Wang - Technical privacy compliance"
        - "Robert Chen - AdTech implementation"

      ARC-ST: 1
        - "Thomas Anderson - Regulatory strategy"

      ARC-QA: 1
        - "Dr. Jennifer Park - Compliance audit"

  execution_highlights:
    article_22_analysis:
      question: "Does behavioral profiling constitute automated decision-making?"

      analysis:
        - "Profiling IS covered under Article 22 if it produces legal or similarly significant effects"
        - "Personalized advertising can constitute significant effects if it materially affects choices"
        - "Recent EDPB guidance suggests broad interpretation"

      finding: "HIGH RISK - Likely falls under Article 22"

    legitimate_interest_analysis:
      balancing_test:
        controller_interest: "Commercial - advertising revenue"
        data_subject_rights: "Privacy, non-manipulation"
        reasonable_expectations: "Users may not expect behavioral profiling"

      finding: "UNLIKELY VALID - Data subject interests likely prevail"

    compliance_gaps:
      critical:
        - "No valid legal basis for current profiling"
        - "Consent mechanism not GDPR-compliant"
        - "No Article 22 safeguards implemented"

      important:
        - "Privacy notice inadequate for profiling disclosure"
        - "No data protection impact assessment conducted"
        - "Cross-border transfer mechanisms unclear"

  output:
    confidence: 0.88
    verdict: |
      CURRENT STATE: NON-COMPLIANT with GDPR

      Key violations:
      1. Article 22 - Automated decision-making without proper safeguards
      2. Article 6 - No valid legal basis for processing
      3. Article 13/14 - Inadequate transparency

    recommendations:
      immediate:
        - "Cease behavioral profiling until compliant"
        - "Implement valid consent mechanism"
        - "Conduct DPIA"

      medium_term:
        - "Redesign with privacy-by-design principles"
        - "Implement meaningful human oversight"
        - "Consider contextual advertising alternative"

    risk_assessment:
      regulatory_action: "HIGH - €20M or 4% global turnover"
      class_action: "MEDIUM - Especially in privacy-active jurisdictions"
      reputational: "HIGH - Increasing privacy awareness"
```

---

## 6. Engineering Domain Example

### 6.1 Task: Safety-Critical System Review

```yaml
task:
  input: |
    Review the software architecture of an autonomous vehicle emergency
    braking system. The system must meet ISO 26262 ASIL D requirements.
    Focus on fail-safe mechanisms and software fault tolerance.

  domain_detection:
    result:
      primary: "E.ENG.AUT"
      secondary: ["T.DEV.SYS.EMB", "T.SEC.SAF"]
      confidence: 0.96

  precision_calibration:
    result: "PL4 (Verified)"
    override: "Safety-critical ASIL D → PL4 minimum"

  expert_panel:
    size: 17  # Large panel for safety-critical
    composition:
      ARC-TH: 5
        - "Prof. David Chen - Formal methods for safety"
        - "Dr. Anna Morrison - Fault tree analysis"
        - "Dr. Michael Wang - Reliability theory"
        - "Prof. Lisa Park - Control systems theory"
        - "Dr. James Kim - Functional safety standards"

      ARC-AD: 4
        - "Marcus Black - Automotive security"
        - "Dr. Sarah O'Connor - Failure mode analysis"
        - "Thomas Anderson - Adversarial testing"
        - "Dr. Elena Kowalski - Edge case specialist"

      ARC-IM: 4
        - "Dr. Robert Chen - Embedded systems architect"
        - "Jennifer Miller - AUTOSAR specialist"
        - "Dr. David Lee - Real-time systems"
        - "Anna Petrov - Hardware/software integration"

      ARC-QA: 3
        - "Dr. Lisa Martinez - ISO 26262 certification"
        - "Prof. Thomas White - Safety validation"
        - "Dr. Michael Brown - Testing coverage"

      ARC-ST: 1
        - "Dr. Jennifer Park - System architecture"

  execution_highlights:
    architecture_analysis:
      components:
        - "Sensor fusion module"
        - "Decision engine"
        - "Actuator control"
        - "Watchdog and monitoring"

      findings:
        critical:
          - "Single point of failure in decision engine"
          - "Watchdog response time exceeds requirements"

        high:
          - "Sensor fusion lacks diversity requirements"
          - "No graceful degradation mode defined"

    formal_verification:
      methods:
        - "UPPAAL model checking for timing"
        - "SCADE Suite for control logic"
        - "Fault tree analysis with probability"

      results:
        - "Timing: FAIL - 15ms worst case exceeds 10ms requirement"
        - "Logic: PASS - Control logic verified correct"
        - "Fault tree: FAIL - ASIL D target not met"

    iso_26262_gap_analysis:
      Part_3: "Concept phase - PARTIAL"
      Part_4: "Product development system - GAPS IDENTIFIED"
      Part_5: "Product development hardware - OUT OF SCOPE"
      Part_6: "Product development software - MAJOR GAPS"

  output:
    confidence: 0.96
    verdict: |
      CURRENT STATE: DOES NOT MEET ASIL D REQUIREMENTS

      Critical gaps:
      1. Single point of failure violates ASIL D
      2. Timing requirements not verifiably met
      3. Software development process gaps

    recommendations:
      architecture:
        - "Implement redundant decision engine"
        - "Add diverse sensor modalities"
        - "Redesign watchdog for faster response"

      process:
        - "Implement ISO 26262 Part 6 compliant SDLC"
        - "Conduct HARA and derive safety goals"
        - "Establish traceability from hazards to requirements to code"

      verification:
        - "Achieve MC/DC coverage for all safety-critical code"
        - "Implement hardware-in-loop testing"
        - "Third-party safety assessment before production"
```

---

## 7. Cross-Domain Example

### 7.1 Task: Healthcare AI Governance

```yaml
task:
  input: |
    Develop governance framework for deploying AI diagnostic tools
    in a hospital network. Consider clinical effectiveness, patient
    safety, data privacy, liability, and operational integration.

  domain_detection:
    result:
      primary: "X.CROSS"  # Cross-domain
      identified_domains:
        - "S.MED.DIA" (0.85)
        - "T.DAT.ML" (0.80)
        - "L.REG.HEA" (0.75)
        - "L.REG.PRI" (0.72)
        - "B.OPS.MAN" (0.65)
      confidence: 0.83

  precision_calibration:
    result: "PL3"
    rationale: "Healthcare + regulatory requires rigor"

  expert_panel:
    size: 13  # Diverse for cross-domain
    composition:
      # Domain specialists
      - "Dr. Elizabeth Chen - Clinical AI implementation"
      - "Prof. Michael Wang - Medical device regulation"
      - "Dr. Anna Morrison - Health data privacy"
      - "Dr. James Park - Medical liability"
      - "Jennifer Miller - Healthcare operations"

      # Archetype distribution across domains
      ARC-TH: 3
      ARC-AD: 3
      ARC-IM: 3
      ARC-ST: 2
      ARC-QA: 2

  cross_domain_integration:
    pattern_transfers:
      - source: "T.SEC (Security)"
        pattern: "Defense in depth"
        application: "Multiple validation layers for AI decisions"

      - source: "E.ENG (Engineering)"
        pattern: "Fail-safe design"
        application: "AI system defaults to human decision when uncertain"

      - source: "L.LEG (Legal)"
        pattern: "Documented chain of responsibility"
        application: "Clear accountability for AI-assisted decisions"

  output:
    governance_framework:
      clinical_governance:
        - "Clinical validation requirements before deployment"
        - "Ongoing performance monitoring with alert thresholds"
        - "Mandatory human review for high-stakes decisions"
        - "Regular model performance audits"

      safety_governance:
        - "Adverse event reporting system"
        - "Fail-safe defaults when AI uncertain"
        - "Emergency override procedures"
        - "Safety incident investigation protocol"

      privacy_governance:
        - "HIPAA/GDPR compliant data handling"
        - "Patient consent for AI use"
        - "Data minimization in AI training"
        - "Right to human-only care path"

      liability_governance:
        - "Clear decision responsibility documentation"
        - "AI as decision support, not decision maker"
        - "Insurance and indemnification structure"
        - "Vendor accountability requirements"

      operational_governance:
        - "Integration testing requirements"
        - "Staff training and certification"
        - "Change management procedures"
        - "Continuous improvement cycle"

    confidence: 0.89
    key_insight: |
      Cross-domain governance requires treating each domain's
      concerns seriously while finding integrated solutions that
      don't create conflicts between domains.
```

---

## Appendix: Domain Adaptation Summary

| Example | Primary Domain | Precision | Panel Size | Key Insight |
|---------|---------------|-----------|------------|-------------|
| Crypto Protocol | T.SEC.PRO | PL4 | 15 | Nation-state threats require verification |
| Market Entry | B.STR.CPT | PL2 | 9 | Multi-domain strategy needs template fusion |
| Clinical Trial | S.MED.DIA | PL3 | 11 | Medical safety drives minimum precision |
| Privacy Compliance | L.REG.PRI | PL3 | 9 | Regulatory requires formal legal analysis |
| Safety-Critical | E.ENG.AUT | PL4 | 17 | ASIL D requires verified approach |
| Cross-Domain | X.CROSS | PL3 | 13 | Integration patterns from multiple domains |

---

*This document is part of the USF 4.0 specification suite. See MASTER-SPECIFICATION.md for framework overview.*
